Biotech & AI drug discoverySTAT — Biotech

STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

According to STAT, Roche has signed a drug discovery deal with Chinese biotech Defand Therapeutics, focused on molecular glue medicines. Further deal details were not provided in the report.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-08T12:00:00+00:00

Published here2026-10-08T13:49:59+00:00

Original source

STAT — Biotech

Media report · consult original reporting

Read the original ↗https://www.statnews.com/2026/10/08/roche-defand-therapeutics-drug-development-deal/

Original headline

STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.